Zhenwei Su
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
-
- Nanoplatforms for cancer theranostics 8
- Graphene and Nanomaterials Applications 1
-
- Nanoparticle-Based Drug Delivery 7
- Co-authors
- Xintao Shuai (7 shared papers)Zecong Xiao (3 shared papers)Jinsheng Huang (3 shared papers)Shisong Han (3 shared papers)Yong Wang (5 shared papers)Liteng Lin (1 shared paper)Xingyu Jiang (3 shared papers)Yongcheng An (2 shared papers)
- Journals
- Biomaterials (1 paper)Acta Pharmaceutica Sinica B (1 paper)Chemical Communications (1 paper)Biomaterials Science (1 paper)Journal of Biomedical Nanotechnology (1 paper)
- Partner nations
- ChinaDenmarkNew Zealand
In The Last Decade
Zhenwei Su
12 papers receiving 587 citations
Peers
Comparison fields: 5 of 69
- Biomaterials 185
- Immunology 161
- Biomedical Engineering 321
- Oncology 142
- Molecular Medicine 16
Countries citing papers authored by Zhenwei Su
This map shows the geographic impact of Zhenwei Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenwei Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenwei Su more than expected).
Fields of papers citing papers by Zhenwei Su
This network shows the impact of papers produced by Zhenwei Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenwei Su. The network helps show where Zhenwei Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhenwei Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 140 | |
| 2 | 2020 | 130 | |
| 3 | 2020 | 102 | |
| 4 | 2021 | 47 | |
| 5 | 2023 | 31 | |
| 6 | 2019 | 30 | |
| 7 | 2015 | 29 | |
| 8 | 2017 | 27 | |
| 9 | 2023 | 26 | |
| 10 | 2024 | 12 | |
| 11 | 2020 | 11 | |
| 12 | 2025 | 4 |
About Zhenwei Su
Zhenwei Su is a scholar working on Biomedical Engineering, Biomaterials, Oncology, Immunology and Molecular Biology, having authored 12 papers that have together received 589 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (7 papers), Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), RNA Interference and Gene Delivery (2 papers), Advanced biosensing and bioanalysis techniques (1 paper), Hepatocellular Carcinoma Treatment and Prognosis (1 paper) and Graphene and Nanomaterials Applications (1 paper). The work is most often cited by research in Biomaterials (185 citations), Immunology (161 citations), Biomedical Engineering (321 citations), Oncology (142 citations) and Molecular Medicine (16 citations). Zhenwei Su has collaborated with scholars based in China, Denmark and New Zealand. Frequent co-authors include Xintao Shuai, Zecong Xiao, Jinsheng Huang, Shisong Han, Yong Wang, Liteng Lin, Xingyu Jiang, Yongcheng An, Shaowei Dong and Chang Zou. Their work appears in journals such as Biomaterials, Acta Pharmaceutica Sinica B, Chemical Communications, Biomaterials Science and Journal of Biomedical Nanotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.